Evaluating Slow-Release Oral Morphine to Narrow the Treatment Gap for Opioid Use Disorders

The opioid epidemic has garnered widespread attention and concern. Although evidence-based treatments for opioid use disorders exist, health system and regulatory barriers may limit their use. In this commentary, the authors discuss the need for further investigation into slow-release oral morphine as a potential treatment for patients with these disorders.

http://ift.tt/2C90IpW